This funding round was led by existing investors including Felicis Ventures and Manta Ray, bringing Supplant's funding to $24 million. Previously known as Cambridge Glycoscience, the company develops oligosaccharide-based sweetener...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)